Pharmaust Ltd
ASX:PAA
Pharmaust Ltd
ASX:PAA
Price:
0.165
AUD
-8.33%
Market Closed
Market Cap:
AU$81.2m
Balance Sheet
Balance Sheet Decomposition
Pharmaust Ltd
Pharmaust Ltd
Balance Sheet Decomposition is not available for
Pharmaust Ltd
Pharmaust Ltd
Balance Sheet
Pharmaust Ltd
Pharmaust Ltd
Currency: AUD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
1
|
3
|
2
|
2
|
3
|
3
|
2
|
3
|
10
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
3
|
10
|
|
| Cash Equivalents |
3
|
1
|
3
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
4
|
1
|
3
|
3
|
3
|
4
|
4
|
4
|
3
|
11
|
|
| PP&E Net |
1
|
2
|
2
|
2
|
2
|
4
|
3
|
3
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
0
|
|
| Intangible Assets |
5
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
|
| Total Assets |
10
N/A
|
6
-34%
|
8
+31%
|
8
+2%
|
9
+3%
|
11
+25%
|
11
+2%
|
10
-8%
|
6
-39%
|
11
+81%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+81%
|
1
+4%
|
1
-5%
|
1
-7%
|
2
+95%
|
2
-7%
|
2
+8%
|
2
+0%
|
1
-60%
|
|
| Equity | |||||||||||
| Common Stock |
44
|
44
|
48
|
49
|
51
|
54
|
55
|
55
|
58
|
70
|
|
| Retained Earnings |
36
|
39
|
41
|
42
|
44
|
45
|
46
|
47
|
54
|
60
|
|
| Total Equity |
9
N/A
|
5
-43%
|
7
+38%
|
7
+3%
|
7
+4%
|
9
+14%
|
9
+4%
|
8
-12%
|
4
-50%
|
10
+163%
|
|
| Total Liabilities & Equity |
10
N/A
|
6
-34%
|
8
+31%
|
8
+2%
|
9
+3%
|
11
+25%
|
11
+2%
|
10
-8%
|
6
-39%
|
11
+81%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
105
|
106
|
173
|
219
|
280
|
302
|
317
|
317
|
347
|
445
|
|
Switch to:
Switch to:
See Also
Discover More
